US 10195297
Iron garnet nanoparticles for cancer radiotherapy and chemotherapy
granted A61KA61K2300/00A61K31/555
Quick answer
US patent 10195297 (Iron garnet nanoparticles for cancer radiotherapy and chemotherapy) held by The Board of Regents of the University of Texas System expires Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Feb 05 2019 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jan 31 2039 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 11
- CPC classes
- A61K, A61K2300/00, A61K31/555, A61K33/00, A61K33/22